Radiopharm Theranostics Health Care
Biotech Cancer Healthcare Medical

$0.105 -0.010 (-8.70%)

High $0.12	Low $0.10	Trades 57	Turnover $206,557	Volume 1,951,148
30 June 2023 at 4:10pm

Market Cap (13-Aug) $30,744,344 (0th)	Close (30-Jun) $0.105 0 (0%)	Volume (30-Jun) 1,951,148	Shortsold (3-Aug) 875,237 (0.02%) (547th)
52w High $0.040	52w Low $0.010	P/E -	EPS -0.02

Short Interest

ASIC data, 3 Aug 2026

% Shorted

0.02% 0.24

vs 0.26% prior report

Most Shorted Rank

547th

of 704 shorted ASX stocks

Peak Short

0.48%

Dec 2025

Days to Cover

0.2

at 50d avg vol

View full short position history →

	Subject
	RAD RAD Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	1 (current) 2 3
	RAD RAD Ann: GenesisCare agreement extended to prostate cancer trial
	RAD RAD Ann: Dr Susann Brady-Kalnay added to Scientific Advisory Board
	RAD RAD Ann: Investor webinar - RAD adds brain tumor technology
	RAD RAD Ann: Supply agreement with Isotopia for Lutetium-177
	RAD RAD Ann: Investor Presentation
	RAD RAD Ann: RAD adds Brain Tumor Technology to Portfolio
	RAD RAD Ann: Initial Director's Interest Notice - LA
	RAD RAD Ann: RAD Appoints Dr Leila Alland as Non-Executive Director
	RAD RAD Ann: Industry leader Vittorio Puppo appointed COO
	RAD RAD Ann: Notification regarding unquoted securities - RAD
	RAD RAD Ann: Notice Under Section 708A
	RAD RAD Ann: Application for quotation of securities - RAD
	RAD RAD Ann: RAD presentation to Bioshares Biotech Summit
	RAD RAD Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	RAD RAD Ann: Virtual investor conference presentation 2 May 2022
	RAD RAD Ann: Change of Director's Interest Notice - PH
	RAD RAD Ann: Change of Director's Interest Notice - IT
	RAD RAD Ann: Change of Director's Interest Notice - RC
	RAD RAD Ann: RAD Dual Action Antibody Investor Deck
	RAD RAD Ann: RAD Licenses UCLA Dual Action Antibody
	RAD RAD Ann: Change of Director's Interest Notice - HL
	RAD RAD Ann: Investor Presentation
	RAD RAD Ann: LOI with GenesisCare to start first trial in Australia
	RAD RAD Article: Biotech CEOs hit the streets amid sector sell-off
	RAD RAD Ann: Change of Director's Interest Notice - IT
	RAD RAD Ann: Half Yearly Report and Accounts
	RAD RAD Ann: Change in substantial holding NT
	RAD RAD Ann: Radiopharm and Terrapower supplementary announcement
	RAD RAD Ann: Initial Director's Interest Notice - HL
	RAD RAD Ann: Hester Larkin appointed as Non-Executive Director
	RAD RAD Ann: Director Appointment/Resignation
	RAD RAD Ann: Radiopharm and TerraPower sign Actinium 225 agreement
	RAD RAD Ann: Application for quotation of securities - RAD
	RAD RAD Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	RAD RAD Ann: Proposed issue of securities - RAD
	RAD RAD Ann: RAD acquires IP Ownership of Radiopharmaceutical Nanobodies
	RAD RAD Ann: Change of Director's Interest Notice - RC
	RAD RAD Ann: RAD to present at Biotech Showcase
	RAD RAD Ann: Expansion of RAD management team
	RAD RAD Ann: Completion of Phase 1 imaging study in breast cancer
	RAD RAD Ann: Change of Director's Interest Notice - IT
	RAD RAD Ann: Change of Director's Interest Notice - PH
	RAD RAD Ann: Letter to shareholders
	RAD RAD Ann: Change of Director's Interest Notice - RC
	RAD RAD Ann: RAD Integrins technology featured in Cancers journal
	RAD RAD Ann: Dr Sara Hurvitz appointed to Scientific Advisory Board
	RAD RAD Ann: Change of Director's Interest Notice - IT
	RAD RAD Ann: Becoming a substantial holder - NT
	RAD RAD Ann: Change of Director's Interest Notice - PH

End of Day Prices

Date	Close	Volume	Change
13-Aug	$0.01	36,047,834	0.00 (0.00%)
12-Aug	$0.01	2,821,873	0.00 (7.69%)
11-Aug	$0.01	2,139,520	0.00 (0.00%)
10-Aug	$0.01	1,763,436	+0.00 (8.33%)
07-Aug	$0.01	1,288,970	0.00 (7.69%)
06-Aug	$0.01	6,652,609	0.00 (7.14%)
05-Aug	$0.01	6,825,756	+0.00 (7.69%)
04-Aug	$0.01	14,109,854	0.00 (0.00%)
03-Aug	$0.01	16,021,248	0.00 (7.14%)
31-Jul	$0.01	18,887,112	0.00 (0.00%)
30-Jul	$0.01	8,497,904	0.00 (0.00%)
29-Jul	$0.01	6,294,905	0.00 (6.67%)
28-Jul	$0.02	9,719,578	+0.00 (7.14%)
27-Jul	$0.01	31,523,199	-0.01 (26.32%)
24-Jul	$0.02	0	0.00 (0.00%)
3 up, 6 down, and 6 flat days

Radiopharm Theranostics Health Care
Biotech Cancer Healthcare Medical

Short Interest

Followers

Prices

Announcements

End of Day Prices

RAD Radiopharm Theranostics Health Care Biotech Cancer Healthcare Medical

Short Interest

Followers

Prices

Announcements

End of Day Prices

Radiopharm Theranostics Health Care
Biotech Cancer Healthcare Medical